Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice-Reference-Cited by-同舟云学术

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

Published:2009-05-01 Issue:5 Volume:119 Page:1216-1229
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Qing Jing,Du Xiangnan,Chen Yongmei,Chan Pamela,Li Hao,Wu Ping,Marsters Scot,Stawicki Scott,Tien Janet,Totpal Klara,Ross Sarajane,Stinson Susanna,Dornan David,French Dorothy,Wang Qian-Rena,Stephan Jean-Philippe,Wu Yan,Wiesmann Christian,Ashkenazi Avi

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference49 articles.

1. Cellular signaling by fibroblast growth factor receptors

2. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis

3. Mechanisms underlying differential responses to FGF signaling

4. Structural basis for fibroblast growth factor receptor activation

5. Fibroblast growth factor signaling in tumorigenesis

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

2. A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants;Cancer Research;2024-07-02

3. Changes in mouse epidermal DNA methylation during development of squamous cell carcinoma in response to UVR;Experimental Dermatology;2024-06

4. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression;Blood Cancer Journal;2024-04-29

5. Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review;Discover Oncology;2024-04-11